Correlation Between AN2 Therapeutics and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Cullinan Oncology LLC, you can compare the effects of market volatilities on AN2 Therapeutics and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Cullinan Oncology.
Diversification Opportunities for AN2 Therapeutics and Cullinan Oncology
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between AN2 and Cullinan is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Cullinan Oncology go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Cullinan Oncology
Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 1.39 times more return on investment than Cullinan Oncology. However, AN2 Therapeutics is 1.39 times more volatile than Cullinan Oncology LLC. It trades about 0.21 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.24 per unit of risk. If you would invest 110.00 in AN2 Therapeutics on August 29, 2024 and sell it today you would earn a total of 29.00 from holding AN2 Therapeutics or generate 26.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AN2 Therapeutics vs. Cullinan Oncology LLC
Performance |
| Timeline |
| AN2 Therapeutics |
| Cullinan Oncology LLC |
AN2 Therapeutics and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and Cullinan Oncology
The main advantage of trading using opposite AN2 Therapeutics and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| AN2 Therapeutics vs. Eliem Therapeutics | AN2 Therapeutics vs. Scpharmaceuticals | AN2 Therapeutics vs. Milestone Pharmaceuticals | AN2 Therapeutics vs. Seres Therapeutics |
| Cullinan Oncology vs. Eliem Therapeutics | Cullinan Oncology vs. Scpharmaceuticals | Cullinan Oncology vs. Milestone Pharmaceuticals | Cullinan Oncology vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |